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Background: HMGB1 is a proinflammatory cytokine produced in response to tissue injury, but its role in ALD is unknown.
Results: HMGB1 increases; translocates; and undergoes acetylation, phosphorylation, and oxidation in ALD. HMGB1 ablation
in hepatocytes protects against steatosis and injury in ALD.
Conclusion: HMGB1 plays a key role in ALD.
Significance: Dissecting how the increase in HMGB1 causes hepatotoxicity is key for understanding the pathogenesis of ALD.
Growing clinical and experimental evidence suggests that
sterile inflammation contributes to alcoholic liver disease
(ALD). High mobility group box-1 (HMGB1) is highly induced
during liver injury; however, a link between this alarmin and
ALD has not been established. Thus, the aim of this work was to
determine whether HMGB1 contributes to the pathogenesis of
ALD. Liver biopsies from patients with ALD showed a robust
increase in HMGB1 expression and translocation, which corre-
lated with disease stage, compared with healthy explants. Simi-
lar findings were observed in chronic ethanol-fed wild-type
(WT) mice. Using primary cell culture, we validated the ability
of hepatocytes from ethanol-fed mice to secrete a large amount
of HMGB1. Secretion was time- and dose-dependent and
responsive to prooxidants and antioxidants. Selective ablation
of Hmgb1 in hepatocytes protected mice from alcohol-induced
liver injury due to increased carnitine palmitoyltransferase-1,
phosphorylated 5AMP-activated protein kinase-, and
phosphorylated peroxisome proliferator-activated receptor-
expression along with elevated LDL plus VLDL export. Native
and post-translationally modified HMGB1 were detected in
humans and mice with ALD. In liver and serum from control
mice and in serum from healthy volunteers, the lysine residues
within the peptides containing nuclear localization signals
(NLSs) 1 and 2 were non-acetylated, and all cysteine residues
were reduced. However, in livers from ethanol-fed mice, in addi-
tion to all thiol/non-acetylated isoforms of HMGB1, we
observed acetylated NLS1 and NLS2, a unique phosphorylation
site in serine 35, and an increase in oxidation of HMGB1 to the
disulfide isoform. In serum from ethanol-fed mice and from
patients with ALD, there was disulfide-bonded hyperacetylated
HMGB1, disulfide-bonded non-acetylated HMGB1, and HMGB1
phosphorylated in serine 35. Hepatocytes appeared to be a
major source of these HMGB1 isoforms. Thus, hepatocyte
HMGB1 participates in the pathogenesis of ALD and undergoes
post-translational modifications (PTMs) that could condition
its toxic effects.
Alcoholic liver disease (ALD)4 is a major cause of morbidity
and mortality worldwide. The spectrum of disease ranges from
simple fatty liver to steatohepatitis, progressive fibrosis, cirrho-
sis, and hepatocellular carcinoma. In developed countries, ALD
is a major cause of end stage disease that requires liver trans-
plantation. Therefore, identifying proinflammatory proteins
that are critical in the pathogenesis of ALD and that could be
used as biomarkers of disease progression is vital for diagnostic
purposes, for patient stratification, and to improve the quality
of life in many patients.
High mobility group box-1 (HMGB1) is a highly conserved
eukaryotic non-histone chromosomal protein of 215 amino
acids with a tripartite structure composed of two DNA-binding
domains (box A and box B) and an acidic C-terminal domain
containing aspartate and glutamate residues (1). Upon stimu-
lation, HMGB1 undergoes translocation from the nucleus to
the cytoplasm, and it is then secreted via the lysosomal pathway
in most cells (2, 3), by exosomes in enterocytes (4, 5), or by the
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inflammasome in immune cells (6 –10). HMGB1 binds the
receptor for advanced glycation end products, toll-like recep-
tors-2/4/9, Mac-1, syndecan-1, phosphacan protein-tyrosine
phosphatase-/, and CD24 (11–15).
Initially, it was believed that this non-sequence-specific
DNA-binding protein with two nuclear localization signals
(NLSs) acted primarily as an architectural element. Among
its well known roles in the nucleus, HMGB1 activates or inhib-
its transcription (16 –18); modulates DNA repair (19); pro-
motes nucleoprotein complex assembly (20); facilitates nucleo-
some disruption and remodeling (21); acts as a cofactor in
mammalian base excision repair (22); and participates in
recombination (23), suppression of genotoxic stress signaling
(24), and maintenance of chromatin in a fluidic state (25).
However, work over the past decade has demonstrated that
HMGB1 also has critical effects in the extracellular environ-
ment. When passively released from injured or necrotic cells
due to loss of membrane integrity (26) or when secreted by
activated monocytes and macrophages as a delayed response to
lipopolysaccharide (LPS), IL-1, or TNF, HMGB1 can trigger
an inflammatory response (27). Indeed, administration of neu-
tralizing HMGB1 antibodies prevents inflammation and atten-
uates disease severity (27–29). Thus, HMGB1 is now consid-
ered a member of the family of damage-associated molecular
patterns that communicate injury, inflammation, and death to
neighboring cells.
In all cells, HMGB1 shuttles bidirectionally between the
nucleus and cytoplasm via passive and active mechanisms.
Under physiological conditions, nuclear import is more favor-
able than export. However, increased nuclear export in
response to stimuli and post-translational modifications
(PTMs) drives HMGB1 toward cytoplasmic localization and
secretion (1, 30 –35). It has been reported that HMGB1 can
undergo phosphorylation, acetylation, oxidation, methylation,
ADP-ribosylation, and glycosylation (36).
To date, a comprehensive qualitative and quantitative analysis
of HMGB1 and its PTMs in ALD is lacking. Because inflammation
is a key component contributing to the pathogenesis of ALD and
HMGB1 is an early proinflammatory cytokine up-regulated in
response to sterile and non-sterile tissue injury, the aims of this
study were to determine whether HMGB1 increases in ALD,
quantify the extent of HMGB1 translocation from the nucleus to
the cytoplasm in ALD, dissect whether HMGB1 induction in
hepatocytes is essential for alcohol-induced liver injury, dissect the
mechanism involved, identify the PTMs of HMGB1 in ALD, and
recognize whether native HMGB1 and post-translationally modi-
fied HMGB1 are secreted into the extracellular space under alco-
hol consumption. To this aim, we used samples from patients with
ALD and mouse models of alcohol-induced liver injury along with
primary cell culture as well as conditional ablation of Hmgb1 in
hepatocytes in vivo.
EXPERIMENTAL PROCEDURES
General Methodology—Alanine aminotransferase activity
and triglycerides were analyzed using kits (Pointe Scientific,
Canton, MI). Hematoxylin and eosin (H&E) staining and Sirius
red/fast green staining for collagenous proteins and Western
blot analysis for HMGB1, nitric-oxide synthase-2, 3-nitroty-
rosine, and calnexin were performed as in earlier work (37). All
the antibodies used were from Santa Cruz Biotechnology
(Santa Cruz, CA). Secreted proteins were concentrated by ace-
tone precipitation. Primary mouse hepatocytes, Kupffer cells,
stellate cells, and sinusoidal endothelial cells were isolated as
described previously (38). Transmission electron microscopy
and measurement of cytochrome P450 2E1 activity, lipid per-
oxidation, H2O2, O2
. , total and mitochondrial GSH, and TNF
were performed as in previous publications (37, 39). The con-
centration of HMGB1 was measured by ELISA using a kit from
IBL International (Toronto, Canada). LDL and VLDL were
measured using a kit from Biovision (Milpitas, CA).
Human Samples—Dr. Fiel provided paraffin-embedded
archived wedge samples from six de-identified healthy human
lobectomy specimens and human liver needle biopsies from 12
patients with clinically proven alcohol-induced liver injury
scored according to the Brunt classification (40). Dr. Branch
provided serum from 10 de-identified individuals with ALD
and from controls. These archived samples were Institutional
Review Board-approved. Control sera were also obtained from
laboratory personnel. In all cases, no patient information was
disclosed.
Mice—In the Hmgb1fl/fl mice, the Hmgb1loxP allele was cre-
ated by inserting loxP sites within introns 1 and 2 flanking exon 2
of Hmgb1 (41). These mice were donated by Dr. Billiar (University
of Pittsburgh, Pittsburgh, PA) and were bred with Alb-Cre mice
(The Jackson Laboratory, Bar Harbor, ME) to generate hepato-
cyte-specific Hmgb1fl/flAlb-Cre mice. Hmgb1fl/fl/Alb-Cre
mice were used as control littermates. Hmgb1 ablation in hepa-
tocytes was confirmed by genotyping using both tail and liver
DNA and by immunohistochemistry (IHC). Minor differences
in hepatocyte mRNA expression were found by the donating
investigators at baseline between Hmgb1fl/flAlb-Cre mice and
Hmgb1fl/fl/Alb-Cre control littermates (41).
Lieber-DeCarli Model of Early Alcohol-induced Liver
Injury—To provoke early alcohol-induced liver injury, we used
the control and ethanol Lieber-DeCarli diets (42) (Bio-Serv
Inc., Frenchtown, NJ), which are equicaloric and have compa-
rable composition of fat (42% of total calories) and protein (16%
of total calories). The content of carbohydrates is 42% of total
calories (dextrin-maltose) in the control diet and 12% of total
calories in the ethanol diet where up to 30% of carbohydrate calo-
ries are replaced by ethanol (42). 10-week-old male wild-type
(WT) mice or Hmgb1fl/flAlb-Cre and Hmgb1fl/fl/Alb-Cre con-
trol littermates were used in the Lieber-DeCarli model. Mice
were acclimatized to the liquid diet regime by feeding them the
control diet for 3 days. The percentage of ethanol-derived cal-
ories was progressively increased from 10% (1 week) to 20% (1
week), 25% (2 weeks), and 30% (3 weeks). Mice were pair-fed,
and body weight was monitored throughout the experiment.
Liver and body weights were recorded at the point of sacrifice to
calculate the liver-to-body weight ratio for each mouse. Blood
was collected by submandibular bleeding under anesthesia, and
livers were removed for further analysis. All animals received
humane care according to the criteria outlined in the “Guide for
the Care and Use of Laboratory Animals” prepared by the
National Academy of Sciences and published by the National
Institutes of Health.
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Pathology—The entire mouse left liver lobe was resected,
fixed in 10% neutral buffered formalin, and processed into par-
affin sections for H&E staining or IHC. Blind analysis by our
liver pathologist was used to determine the activity scores
according to the Brunt classification (40). Ten 100 fields per
liver section from the same mouse were examined for steatosis
and necroinflammatory activity, which was scored as follows: 0
for none, 1 for 2 foci per 100 field, 2 for 2– 4 foci per 100
field, 3 for 5–10 foci per 100 field, and 4 for 10 foci per 100
field. The density of the necroinflammatory activity was also
calculated per mm2 per 100 fields.
Immunohistochemistry—Archived wedge samples from
human lobectomy healthy specimens, human liver needle biop-
sies from patients with ALD, and control or ethanol-fed mice
were immunostained for HMGB1 following standard proce-
dures. The HMGB1 antibody (ab18256) was from Abcam
(Cambridge, MA). Immunochemical reactions were developed
using the Histostain Plus detection system (Invitrogen). The
intensity of the immunostaining was quantified by computer-
assisted morphometry assessment. The integrated optical den-
sity was calculated in 10 random fields per section containing
similar size portal tracts or central veins at 100 using Image-
Pro Plus 7.0 Software (Media Cybernetics, Bethesda, MD). The
intensity of the red area corresponding to HMGB1-positive
staining in the scanned fields was averaged and considered the
total HMGB1-positive staining. Next, the software settings
were programmed to select all nuclei, and the intensity of the
stained red area corresponding to nuclear HMGB1-positive
staining in the scanned fields was averaged and considered the
nuclear HMGB1-positive staining. The nuclear staining was
then subtracted from the total staining to determine the cyto-
plasmic HMGB1-positive staining. The results were averaged
and expressed as -fold change of the controls. The HMGB1
expression ratios were calculated by morphometry analysis as
above in 20 fields per slide at 200 magnification and are
expressed as nuclear versus total and cytoplasmic versus total
HMGB1 expression. Immunofluorescences were performed on
primary hepatocytes, Kupffer cells, stellate cells, and sinusoidal
endothelial cells using the same HMGB1 antibody as above
followed by Alexa Fluor 488-conjugated goat anti-rabbit IgG
secondary antibody (Invitrogen) and visualized by confocal
microscopy.
Analysis of Serum and Liver HMGB1 by Electrospray Ioniza-
tion-Liquid Chromatography-Mass Spectrometry (ESI-LC-
MS)—All chemicals and solvents used were of the highest
available grade (Sigma). Samples were precleared with 50 l of
protein G-Sepharose beads for 1 h at 4 °C. HMGB1 present in
serum or liver was immunoprecipitated with 5 g of rabbit
anti-HMGB1 (ab18256) for 16 h at 4 °C as described previously
(43). For the analysis of HMGB1 PTMs, free thiol groups within
HMGB1 were alkylated for 90 min with 10 mM iodoacetamide
at 4 °C. Cysteine residues in disulfide bonds were then reduced
with 30 mM dithiothreitol at 4 °C for 1 h followed by alkylation
of newly exposed thiol groups with 90 mM N-ethylmaleimide at
4 °C for 10 min. Samples were subjected to trypsin (Promega,
Madison, WI) or Glu-C (New England Biolabs, Ipswich, MA)
digestion according to the manufacturers’ instructions and
desalted using C18 ZipTips (Millipore, Billerica, MA). Charac-
terization of whole protein molecular weights, acetylated lysine
residues, or redox modifications on cysteine residues within
HMGB1 was performed as described previously by whole pro-
tein ESI or tandem mass spectrometry (MS/MS) (44 – 46) using
either an AB Sciex QTRAP 5500 or an AB Sciex TripleTOF
5600 (Sciex Inc., Framingham, MA). Peptide analysis was deter-
mined using an AB Sciex QTRAP 5500 equipped with a Nano-
Spray II source by in-line liquid chromatography using a U3000
HPLC system (Dionex, Sunnyvale, CA), connected to a 180-
m  20-mm nanoAcquity UPLC C18 trap column and a
75-m  15-cm nanoAcquity UPLC BEH130 C18 column
(Waters, Milford, MA) via reducing unions. A gradient from
0.05% TFA (v/v) to 50% acetonitrile, 0.08% TFA (v/v) in 40 min
was applied at a flow rate of 200 nl/min. The ion spray potential
was set to 2,200 –3,500 V, the nebulizer gas was set to 19 L/min,
and the interface heater was set to 150 °C.
Statistical Analysis—Data were analyzed by a two-factor
analysis of variance, and results were expressed as means  S.E.
(n  10 –12/group for the human samples and the Lieber-De-
Carli model).
RESULTS
Liver Biopsies from Patients with Acute Alcoholic Steatohepa-
titis (ASH) Superimposed on ALD and Cirrhosis Show Signifi-
cant and Progressive Increase in HMGB1 Expression and Trans-
location from the Nucleus to the Cytoplasm Compared with
Wedge Samples from Healthy Human Lobectomy Specimens—
To determine whether HMGB1 increases in ALD, wedge sam-
ples from healthy human lobectomy specimens and liver needle
biopsies from patients with clinically proven acute ASH super-
imposed on ALD and cirrhosis, as shown by H&E and Sirius
red/fast green staining (Fig. 1A), were analyzed for HMGB1
expression. The IHC analysis demonstrated a robust increase in
HMGB1 expression in patients with acute ASH superimposed
on ALD and cirrhosis compared with healthy specimens (Fig.
1B, top). There was a significant increase in HMGB1 expression
and in HMGB1 translocation from the nucleus to the cytoplasm
that was more apparent in hepatocytes. This was quantified by
morphometry assessment and calculation of the increase in
total, nuclear, and cytoplasmic HMGB1 along with the ratios of
nuclear versus total and cytoplasmic versus total HMGB1 pro-
tein expression (Fig. 1B, bottom).
To dissect whether HMGB1 expression correlated with the
extent of alcohol-induced liver damage, we performed IHC
analysis for HMGB1 in a set of human liver specimens that
ranged from healthy to stages 2 (mild), 3 (significant), and 4
(severe) alcohol-induced liver injury classified according to the
Brunt scoring system (40). HMGB1 expression and transloca-
tion correlated with the degree of alcohol-induced liver injury
(Fig. 2). Overall, these results suggest that patients with ALD
show a progressive increase in HMGB1 expression and trans-
location compared with healthy liver specimens.
Alcohol Intake Enhances HMGB1 Expression and Transloca-
tion from the Nucleus to the Cytoplasm in WT Mice—To carry
out mechanistic studies to understand how ethanol increases
HMGB1 expression and nucleocytoplasmic shuttling, mouse
models of ALD and genetic approaches are needed. Hence, we
questioned whether the changes in HMGB1 expression and
HMGB1 and ALD
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cellular localization observed in patients would also occur in
mouse models of ALD. To this end, WT mice were fed either
the control or the ethanol Lieber-DeCarli diet, a model known
to cause early alcohol-induced liver injury (42). Mice fed etha-
nol showed a 20% increase in the liver-to-body weight ratio
compared with mice fed the control diet (not shown). H&E
staining revealed more liver injury and steatosis in ethanol-fed
mice than in control mice (Fig. 3A, top). Serum alanine amino-
transferase activity and serum and liver triglycerides were
higher following ethanol feeding, suggesting increased liver
damage compared with mice fed the control diet. Further-
more, the scores for steatosis, inflammation, and necrosis
were higher in ethanol-fed mice compared with control mice
(Fig. 3A, bottom). Ethanol induced HMGB1 expression and
abundant cytoplasmic localization compared with mice fed
control diet (Fig. 3B, top). This was quantified by morphometry
assessment of total, nuclear, and cytoplasmic HMGB1 expres-
sion (Fig. 3B, middle) and by Western blot analysis (Fig. 3B,
bottom), both of which proved a decrease in nuclear versus total
along with an increase in cytoplasmic versus total HMGB1
expression.
To validate that the increase in HMGB1 expression and
translocation from the nucleus to the cytoplasm was specific,
we used two additional models of alcohol-induced liver injury.
For this purpose, we performed the chronic-plus-single binge
ethanol feeding model of alcohol-induced liver injury (47). In
addition, we obtained samples from a mouse model of alcoholic
neutrophilic hepatitis developed in Dr. Tsukamoto’s laboratory
FIGURE 1. Liver biopsies from patients with ASH superimposed on ALD and cirrhosis show significant increase in HMGB1 expression and
translocation from the nucleus to the cytoplasm compared with wedge samples from healthy human lobectomy specimens. H&E staining shows
significant steatosis (black arrow), inflammation (orange arrow), and cirrhosis (blue arrow), and Sirius red/fast green staining shows total collagen (red)
in healthy human lobectomy specimens and liver needle biopsies from patients with clinically proven acute ASH superimposed on ALD and cirrhosis (A).
In HMGB1 IHC, the red arrows indicate HMGB1 positive staining in the nucleus and -negative staining in the cytoplasm, and the yellow arrow points to
HMGB1-negative staining in the nucleus and -positive staining in the cytoplasm (B, top). Morphometry assessment of total, nuclear, and cytoplasmic
HMGB1 expression as well as the ratios of nuclear versus total and cytoplasmic versus total HMGB1 expression is shown (B, bottom). n  10/group. *, p 
0.05; **, p  0.01 for ALD versus healthy.
HMGB1 and ALD
AUGUST 15, 2014 • VOLUME 289 • NUMBER 33 JOURNAL OF BIOLOGICAL CHEMISTRY 22675
using a high cholesterol and high fat diet plus intragastric
administration of alcohol along with a weekly alcohol binge
(49). In both models, IHC analysis showed considerable induc-
tion and translocation of HMGB1 in the livers from ethanol-fed
mice compared with the respective control mice (not shown).
Overall, these results demonstrate that in three mouse models
of alcohol-induced liver injury alcohol intake enhances
HMGB1 expression and translocation from the nucleus to the
cytoplasm in mice similarly to what occurs in humans.
Primary Hepatocytes and Kupffer Cells from Control and Eth-
anol-fed Mice Retain Their Phenotype in Vitro—To determine
the contribution of each liver cell type to the increase in
HMGB1 production, primary hepatocytes and Kupffer cells
from control and ethanol-fed mice (HControl, HEtOH, KCControl,
and KCEtOH) were isolated and cultured up to 48 h. Cells were
viable as shown by the typical morphology in the bright field
images (Fig. 4, A and B, top) and by the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide assay and lactate dehy-
drogenase leakage (not shown). Transmission electron micros-
copy also confirmed the ability of HEtOH to retain key features
such as the presence of lipid droplets and electron-dense mito-
chondria and the activated phenotype of KCEtOH (Fig. 4A, mid-
dle). HEtOH showed a significant increase in cytochrome P450
2E1 activity, nitric-oxide synthase-2 expression, 3-nitroty-
rosine, triglycerides, lipid peroxidation-end products (mea-
sured as thiobarbituric acid-reactive substances) and H2O2
production, and a decrease in total and mitochondrial GSH
when compared with HControl (Fig. 4A, bottom). Isolated
Kupffer cells were identified as ED2	 (a marker of Kupffer
cells) and showed phagocytosis of fluorescent red nanopar-
ticles. Moreover, KCEtOH displayed higher TNF expression
and NADPH oxidase activity along with O2
. and H2O2 pro-
FIGURE 2. HMGB1 induction and translocation correlate with disease stage in human ALD. IHC for HMGB1 in a set of human liver biopsies that are healthy
or stage 2 (mild), 3 (significant), and 4 (severe) ALD classified according to the Brunt scoring system (40) is shown. The red arrow indicates HMGB1-positive
staining in the nucleus and -negative staining in the cytoplasm, and the yellow arrows point to HMGB1-negative staining in the nucleus and -positive staining
in the cytoplasm.
HMGB1 and ALD
22676 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289 • NUMBER 33 • AUGUST 15, 2014
duction compared with KCControl (Fig. 4B, bottom). These
findings suggest that the phenotype of isolated primary cells
resembles what typically occurs in vivo under chronic alco-
hol intake (37, 39).
HMGB1 Induction, Translocation, and Secretion in Hepato-
cytes Is Critical for Alcohol-induced Liver Injury—Because of
the high expression of HMGB1 in vivo in hepatocytes and to a
much lesser extent in Kupffer cells, to validate this in vitro, we
performed immunofluorescence analysis in HControl, HEtOH,
KCControl, and KCEtOH. There was significant nuclear localiza-
tion of HMGB1 in HControl, whereas HEtOH showed increased
nuclear HMGB1 expression and a punctate pattern of cytoplas-
mic HMGB1 suggestive of HMGB1 accumulation in the cyto-
plasm perhaps for subsequent secretion (Fig. 4C, top). To con-
firm that indeed secretion occurred, we performed Western
blot analysis to detect HMGB1 in the culture medium, which
validated the ability of hepatocytes to secrete a large amount of
HMGB1 under ethanol treatment (Fig. 4C, bottom). KCControl
did not secrete HMGB1; however, induction of HMGB1
expression and secretion did occur but to a much lesser extent
in KCEtOH than in HEtOH (Fig. 4D). Secretion was undetectable
in stellate cells and sinusoidal endothelial cells despite nuclear
HMGB1 expression (not shown). Moreover, HControl were also
responsive to ethanol treatment, secreting HMGB1 in a dose-
and time-dependent fashion (Fig. 4E). Finally, because ethanol
metabolism causes significant generation of reactive oxygen
FIGURE 3. Alcohol intake enhances HMGB1 expression and translocation from the nucleus to the cytoplasm in WT mice. WT mice were fed for 7 weeks
either the control or the ethanol Lieber-DeCarli diet. H&E staining (steatosis (back arrow), inflammation (orange arrow)), serum alanine aminotransferase (ALT)
activity (units/liter), serum triglycerides (TG) (mg/dl), and liver triglycerides (mg/g of protein) along with the scores for steatosis, inflammation, and necrosis
classified according to the Brunt scoring system (40) are shown (A). IHC shows that ethanol feeding increases HMGB1 expression in WT mice. The red arrows
indicate HMGB1-positive staining in the nucleus and -negative staining in the cytoplasm, and the yellow arrow points to HMGB1-negative staining in the
nucleus and -positive staining in the cytoplasm (B, top). Morphometry assessment of total, nuclear, and cytoplasmic HMGB1 as well as the ratios of nuclear
versus total and cytoplasmic versus total HMGB1 expression is shown (B, middle). Western blot analysis of cytoplasmic and nuclear HMGB1 is also shown (B,
bottom). n  10/group. *, p  0.05; **, p  0.01; ***, p  0.001 for ethanol versus control.
HMGB1 and ALD
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species in the liver, we asked whether hepatocytes will also
increase HMGB1 secretion in response to prooxidant treat-
ment. Both H2O2 and arachidonic acid increased HMGB1
expression and secretion in the absence of cell toxicity as vali-
dated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide assay (not shown); however, HMGB1 induction
FIGURE 4. Primary hepatocytes and Kupffer cells from control and ethanol-fed mice retain their phenotype in vitro. Primary hepatocytes and Kupffer
cells were isolated from mice fed the control or the ethanol Lieber-DeCarli diet for 7 weeks (HControl, HEtOH, KCControl, and KCEtOH) and cultured for up to 48 h.
Bright field pictures along with pictures from hepatocytes fixed and stained with DAPI (blue) are shown (A, top). Transmission electron microscopy pictures from
liver, hepatocytes, and Kupffer cells from control and ethanol-fed mice (the yellow arrows point to lipid droplets, and the pink arrows point to electron-dense
mitochondria) are shown (A, middle). -Fold change of markers of injury in HControl and HEtOH is similar to what occurs in vivo (A, bottom). Bright field pictures from
Kupffer cells (B, top) are shown. Cultured Kupffer cells were fixed and stained with DAPI and ED2 (orange arrow) or evaluated for phagocytic activity of
fluorescent red nanoparticles (blue arrow) (B, bottom left). -Fold change in markers of injury in KCControl and KCEtOH is similar to what occurs in vivo (B, bottom
right). n  6. *, p  0.05; **, p  0.01; ***, p  0.001 for ethanol versus control. HMGB1 induction, translocation, and secretion in hepatocytes are critical for
alcohol-induced liver injury. Immunofluorescence analysis for HMGB1 expression in HControl and HEtOH (C, top) and KCControl and KCEtOH (D, top) at 6 and 24 h
post-isolation is shown. The red arrows indicate HMGB1-positive staining in the nucleus and -negative staining in the cytoplasm, and the yellow arrows point to
loss of HMGB1 staining in the nucleus and appearance of a punctate pattern of positive staining in the cytoplasm. Western blot analysis for secreted HMGB1
in equal amounts of protein from the culture medium from HControl and HEtOH (C, bottom) and KCControl and KCEtOH (D, bottom) is shown. n  3. ***, p  0.001 for
ethanol versus control. HMGB1 secretion in hepatocytes is oxidant stress-sensitive. Primary HControl were treated with 0 –100 mM ethanol for 6 h or with 50 mM
ethanol for 0 – 6 h. Western blot analysis shows that HControl respond to ethanol treatment in a dose- and time-dependent fashion (E). HControl treated with 25
M H2O2 or with 30 M arachidonic acid (AA) for 6 h increased HMGB1 expression and secretion as shown by immunofluorescence and Western blot analysis;
however, the HMGB1 induction and secretion were prevented by co-treatment with 200 units/ml catalase or with 25 M vitamin E, respectively (F). n  3. *, p 
0.05; ***, p  0.001 for treated versus control. ●, p  0.05; ●●●, p  0.001 for co-treated versus control.
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and secretion were prevented by co-treatment with the antiox-
idants catalase (to decompose H2O2) and vitamin E (to block
lipid peroxidation reactions), respectively (Fig. 4F). Hence,
HMGB1 induction and secretion in hepatocytes are oxidant
stress-sensitive.
Next, to determine whether HMGB1 induction and
translocation in hepatocytes played a major role in the devel-
opment of ALD, Hmgb1fl/flAlb-Cre mice and control
Hmgb1fl/fl/Alb-Cre littermates were used. In the absence
of any treatment, these mice show normal liver and kidney
architecture and no obvious phenotype as seen on H&E stain-
ing (Fig. 5A). Cell- and organ-specific Hmgb1 ablation was val-
idated by IHC, which confirmed the absence of HMGB1 mostly
in hepatocytes and not in other cells or organs such as the
kidney (Fig. 5B) (41). Next, Hmgb1fl/flAlb-Cre and control
Hmgb1fl/fl/Alb-Cre littermates were fed the control or the
ethanol Lieber-DeCarli diet as described above. Ethanol-fed
Hmgb1fl/fl/Alb-Cre mice showed enhanced HMGB1 expres-
sion and translocation (Fig. 5C) and developed significant liver
injury and steatosis as shown macroscopically and by H&E stain-
ing, serum alanine aminotransferase, serum and liver triglycerides,
and activity scores (steatosis, inflammation, and necrosis),
whereas Hmgb1fl/flAlb-Cre mice were protected from ALD (Fig.
5D). In summary, these data suggest that HMGB1 induction,
translocation, and secretion in hepatocytes are critical for ALD.
Hmgb1 Ablation Increases Carnitine Palmitoyltransferase-1
(CPT1), Phosphorylated 5-AMP-activated Protein Kinase-
(pAMPK), and Phosphorylated Peroxisome Proliferator-acti-
vated Receptor- (pPPAR) Expression and Enhances LDL plus
VLDL Export, Preventing Steatosis and Liver Injury in Mice—
To identify the mechanism whereby Hmgb1 ablation protected
mice from ALD, we analyzed the expression of the key proteins
involved in fatty acid synthesis and fatty acid -oxidation.
Western blot analysis revealed an increase in the expression of
CPT1, pAMPK, and pPPAR, which are all involved in fatty
acid -oxidation, along with a slight decrease in fatty-acid syn-
thase, which participates in fatty acid synthesis, in ethanol-fed
Hmgb1fl/flAlb-Cre mice compared with Hmgb1fl/fl/Alb-Cre
littermates. However, the expression of PPAR and SREBP1
remained unchanged (Fig. 5E). Moreover, there was enhanced
LDL plus VLDL export from the liver to the serum in ethanol-
fed Hmgb1fl/flAlb-Cre compared with Hmgb1fl/fl/Alb-Cre
FIGURE 4 —continued
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littermates (Fig. 5F). Together, these results suggest that the
up-regulation of CPT1, pAMPK, and pPPAR along with the
enhanced LDL plus VLDL export protects ethanol-fed
Hmgb1fl/flAlb-Cre mice, thus preventing hepatic steatosis and
liver injury compared with their Hmgb1fl/fl/Alb-Cre
littermates.
Identification of HMGB1 Isoforms in Mice and in Patients
with ALD—Recent reports have highlighted the importance of
PTMs within HMGB1 that can condition the mechanism of
cellular HMGB1 secretion and/or its proinflammatory role (1,
30 –35). Identification of these PTMs could contribute to
understanding the pathogenesis of ALD and to developing new
FIGURE 5. Hmgb1fl/flAlb-Cre mice are protected from ALD. H&E staining from liver and kidney from non-treated Hmgb1fl/flAlb-Cre and Hmgb1fl/fl/Alb-Cre
littermates is shown (A). HMGB1 IHC from liver and kidney from non-treated Hmgb1fl/flAlb-Cre mice and Hmgb1fl/fl/Alb-Cre mice is shown (B). The livers from
Hmgb1fl/flAlb-Cre mice confirmed the absence of HMGB1-positive staining in hepatocytes compared with Hmgb1fl/fl/Alb-Cre mice (red arrow). Hmgb1fl/fl
Alb-Cre and Hmgb1fl/fl/Alb-Cre littermates were fed for 7 weeks the control or the ethanol Lieber-DeCarli diet. In IHC for HMGB1, the red arrow indicates
HMGB1 positive staining in the nucleus and negative staining in the cytoplasm, and the yellow arrow points to HMGB1 negative staining in the nucleus and
positive staining in the cytoplasm (C, top). Western blot analysis for HMGB1 in the ethanol-fed mice only is shown (C, bottom). Images show the gross
appearance of the livers from control and ethanol-fed Hmgb1fl/flAlb-Cre and Hmgb1fl/fl/Alb-Cre mice (D, top). H&E staining shows steatosis (black arrow) and
inflammation (orange arrow) (D, middle). Serum alanine aminotransferase (ALT) activity (units/liter), serum triglycerides (TG) (mg/dl), and liver triglycerides
(mg/g of protein) along with the scores for steatosis, inflammation, and necrosis classified according to the Brunt scoring system (40) are shown (D, bottom). n 
10/group. *, p  0.05; **p  0.01 for ethanol versus control. ●, p  0.05; ●●, p  0.01 for Hmgb1fl/flAlb-Cre versus Hmgb1fl/fl/Alb-Cre. Hmgb1 ablation increases
CPT1, pAMPK, and pPPAR expression and enhances LDL plus VLDL export, preventing steatosis and liver injury in mice. Western blot analysis revealed an
increase in the expression of CPT1, pAMPK, and pPPAR in ethanol-fed Hmgb1fl/flAlb-Cre mice compared with Hmgb1fl/fl/Alb-Cre littermates (E). Serum
and liver LDL plus VLDL levels in control and ethanol-fed Hmgb1fl/flAlb-Cre and Hmgb1fl/fl/Alb-Cre mice are shown (F). Results are expressed as average
values  S.E. n  10/group. *, p  0.05; **, p  0.01 for ethanol versus control. ●, p  0.05; ●●●, p  0.001 for Hmgb1fl/flAlb-Cre versus Hmgb1fl/fl/Alb-Cre. PV,
portal vein; CV, central vein.
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therapies. Therefore, we utilized proteomic MS to identify the
HMGB1 isoforms in the liver and serum from mice fed the
Lieber-DeCarli diets and the HMGB1 isoforms circulating in
blood from alcoholic patients.
In control mice, we observed the presence of a single
HMGB1 isoform with a molecular mass of 24,587 Da in both
serum (Fig. 6A) and liver (Fig. 6B). MS analysis confirmed that
the lysine residues within the peptides containing NLS1 (1624 Da)
and NLS2 (1132 Da) were not acetylated (Fig. 6C). Furthermore, all
cysteine residues were in the reduced state as shown by peptides of
1496 (cysteine 23), 549 (cysteine 45), and 2002 Da (cysteine 106)
(Fig. 6D). This all-thiol isoform has been recently termed “fully
reduced HMGB1” (48). These data are consistent with previously
published observations from control mice (28, 46).
In serum and liver from ethanol-fed mice, the above
described all-thiol, non-acetylated HMGB1 isoform was
observed (Fig. 6, E and F). In addition, isoforms of 24,585,
25,467, 25,469, and 25,549 Da were detected (Fig. 6, E and F).
MS analysis revealed that the 24,585-Da isoform was not acety-
lated in NLS1 and in NLS2 (presence of 1624- and 1132-Da
peptides and absence of 1750- and 1342-Da peptides) (Fig. 6G).
Contrary to this, MS analysis revealed that the 25,467-, 25,469-,
FIGURE 5—continued
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FIGURE 6. Identification of HMGB1 PTMs in serum and liver from control and ethanol-fed mice. Representative spectra of whole protein ESI-MS of HMGB1
isoforms isolated from either serum (A) or liver (B) from control mice are shown. Peptide MS of HMGB1 derived from control mouse serum or liver was
performed following enzymatic digestion with either Glu-C to confirm acetyl status (C) or trypsin to confirm redox status (D). Representative spectra of whole
protein ESI-MS of HMGB1 isoforms isolated from either serum (E) or liver (F) from ethanol-fed mice are shown. Peptide MS of HMGB1 derived from serum or liver
from ethanol-fed mice was performed following enzymatic digestion with endopeptidase Glu-C to confirm the lack of acetyl modifications on the 24,587 and
24,585-Da isoforms (G) and the presence of acetyl modifications on the 25,467-, 25,469-, and 25,549-Da isoforms (H). Molecular weights and a schematic
representation of each isoform are indicated on each spectra where required. Acetyl modifications were confirmed on lysine residues (shown as K(Ac)) after
LC-MS/MS analysis for peptides spanning NLS1 (amino acids 27–39) (I) and NLS2 (amino acids 180 –188 (179 –187 minus methionine)) (J) in HMGB1 derived
from mice fed ethanol. Phosphorylation modifications were confirmed on serine 35 (shown as pS35) after LC-MS/MS analysis of NLS1 (K) in HMGB1 derived from
mice fed ethanol. The one-letter amino acid code is given for each peptide sequence, and b and y ions are highlighted with molecular weights where
appropriate. Data are representative of at least six individual mice per group.
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and 25,549-Da isoforms were acetylated in NLS1 and in NLS2
(presence of 1750- and 1342-Da peptides and absence of 1624-
and 1132-Da peptides) (Fig. 6H). Our previous reports have
highlighted these peptides on representative spectra for unre-
lated findings (45, 50). Analysis of b and y ions generated fol-
lowing MS/MS analysis confirmed the acetylation of each lysine
residue within NLS1 (Fig. 6I) and NLS2 (Fig. 6J). b and y ions
were assigned to the corresponding amino acids according to
our previously published methodologies (43, 44, 46, 51). The
increased mass shift of 126 Da for NLS1 and of 210 Da for NLS2
represents the presence of either three or five acetyl modifica-
tions of either NLS1 or NLS2, respectively (Fig. 6, I and J). Addi-
tionally, MS/MS analysis of the 25,549-Da isoform revealed the
presence of a phosphate group on serine 35 (Fig. 6K).
Regarding the redox characterization, we found that the cys-
teine residues within the 24,587-, 25,469-, and the 25,549-Da
isoforms were reduced (as represented in Fig. 6D). In contrast, the
24,585- and 25,467-Da isoforms from the serum and livers of mice
fed ethanol contained only peptides with masses of 1565 (cysteine
23) and 618 Da (cysteine 45), indicating the presence of an isoform
recently termed “disulfide HMGB1” containing a disulfide bond
between cysteines 23 and 45 (48), whereas cysteine 106 remained
in the thiol state (Fig. 7A). In support of these data, MS/MS analysis
of b and y ions generated from these peptides confirmed the amino
acid sequence of each peptide and the addition of an N-ethyl-
maleimide (mass shift of 125 Da) adduct on cysteine 23 (Fig. 7B)
and cysteine 45 (Fig. 7C) and an iodoacetamide adduct (mass shift
of 57 Da) localized to cysteine 106 (Fig. 7D). In summary, for the
analysis of HMGB1 from in vivo studies, schematic overviews of
the PTMs identified on particular isoforms of HMGB1 are shown
in Fig. 6, A, B, E, and F next to the corresponding molecular weight
for ease of interpretation.
As with the analysis of serum and livers of control and etha-
nol-fed mice, the same fingerprint of HMGB1 isoforms was
observed in the serum of healthy volunteers as in the control
mice (Fig. 8A) and in patients with ALD as in the ethanol-fed
mice (Fig. 8B). The same PTMs on these isoforms were also
confirmed by analysis of b and y ions generated during LC-
MS/MS and are all summarized in Table 1. Representative
MS/MS analysis showing lysine acetyl modifications for NLS1
and NLS2 are shown in Fig. 8, C and D. The actual presence of
b and y ions generated in all LC-MS/MS experiments was com-
pared with the predicted observations for that particular pep-
tide sequence using the ExPASy bioinformatics portal. In sum-
mary, chronic alcohol intake induces PTMs in HMGB1;
however, the main cellular source of acetylated, oxidized, and
phosphorylated HMGB1 in the liver remained unknown.
Hepatocytes Are the Major Source of Post-translationally
Modified HMGB1—Because there was significant induction of
HMGB1 under chronic alcohol consumption in hepatocytes
and to a lesser extent in Kupffer cells, next, we asked which cell
type could be the main source of post-translationally modified
HMGB1 in the liver. Using the same strategy as that for liver
and serum samples, MS analysis revealed that HEtOH were the
major source of total, oxidized, acetylated, and phosphorylated
HMGB1, whereas KCEtOH only produced acetylated and phos-
phorylated HMGB1 (Table 2). Thus, HEtOH are not only the major
source of native and post-translationally modified HMGB1, but
they also recapitulate the three PTMs identified in vivo under eth-
anol consumption, whereas KCEtOH only acetylate and phospho-
rylate HMGB1 but to a much lesser extent than HEtOH.
DISCUSSION
In the present study, we demonstrated for the first time that
HMGB1 increases both in liver and serum from patients with
acute ASH superimposed on ALD and cirrhosis and that there
is correlation among the progressive increase in HMGB1
expression, translocation, and secretion with ALD stage in
humans. In addition, in three mouse models of alcohol-induced
liver injury, alcohol intake enhanced hepatic and serum
HMGB1 expression, translocation from the nucleus to the
cytoplasm, and secretion in mice similarly to what occurs in
humans.
Using primary cell culture, we validated the ability of mouse
hepatocytes to secrete a large amount of HMGB1 under ethanol
treatment in vivo and in the absence of significant cell death.
This also occurred, but to a much lesser extent, in Kupffer cells
and was undetectable in stellate cells and sinusoidal endothelial
cells. Furthermore, hepatocytes were also responsive to ethanol
treatment in vitro, increasing, translocating, and secreting
HMGB1 in a dose- and time-dependent fashion. HMGB1
secretion was oxidant stress-sensitive because prooxidants up-
regulated HMGB1 secretion, and the increase was blunted by
co-incubation with the antioxidants catalase and vitamin E.
We next demonstrated that HMGB1 induction and translo-
cation in hepatocytes play a key role in the development of ALD
because selective Hmgb1 ablation in hepatocytes protected
mice from alcohol-induced liver injury. This was due to
increased expression of CPT1, pAMPK, and pPPAR, key
enzymes involved in fatty acid -oxidation, along with efficient
LDL plus VLDL export from the liver into the circulation, hence
preventing steatosis and liver injury.
Moreover, we identified several PTMs from HMGB1 not
previously described within the context of ALD whose func-
tional consequences still remain unknown. We also showed
that native and post-translationally modified HMGB1 are
detected in serum from alcoholic patients and from ethanol-fed
mice. Furthermore, under ethanol consumption, hepatocytes
appeared to be the major source of native and post-translation-
ally modified HMGB1, specifically of oxidized, acetylated, and
phosphorylated HMGB1, whereas Kupffer cells only acetylated
and phosphorylated HMGB1 although to a much lesser extent
than hepatocytes.
Patients and mice with ALD showed the same pattern of
acetylation, phosphorylation, and redox-dependent modifica-
tions in serum HMGB1. Furthermore, mouse liver samples
showed acetylation and phosphorylation of HMGB1 in NLS1 in
addition to acetylation of HMGB1 in NLS2. Moreover, evi-
dence of disulfide bond formation between cysteines 23 and 45
was also observed, most likely as a result of the increased oxi-
dative stress within the livers of these mice under alcohol con-
sumption due to activation of cytochrome P450s and NADPH
oxidase. A unique phosphorylation site in serine 35 localized in
NLS1 was identified in all samples yet, its pathophysiological
role warrants further investigation.
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To date, the publication of the identified HMGB1 isoforms in
samples from clinically relevant human inflammatory diseases
is rather limited. Thus, these findings represent unique novel
data as we describe for the first time the signature of HMGB1
isoforms present in serum during clinical ALD and in both
serum and liver in a mouse model of ALD.
FIGURE 7. LC-MS and LC-MS/MS redox characterization of HMGB1 isoforms in ethanol-fed mice. Representative spectra of the LC-MS characterization of
peptides produced from HMGB1 from the serum of ethanol-fed mice enzymatically cleaved with trypsin (A) are shown. Representative spectra of the LC-MS/MS of
peptides derived from the tryptic digestion of HMGB1 isoforms derived from the serum of ethanol-fed mice covering cysteine residues 23 (B), 45 (C), and 106 (D), which
had been subjected to alkylation by either N-ethylmaleimide or iodoacetamide, are also shown. The one-letter amino acid code is given for each peptide sequence,
and b and y ions are labeled with molecular weights and amino acid code where appropriate. Data are representative of at least six individual ethanol-fed mice.
FIGURE 8. Whole protein ESI-MS and LC-MS/MS characterization of HMGB1 isoforms in healthy volunteers and in patients with ALD. Representative
spectra of whole protein ESI-MS of HMGB1 isoforms isolated from serum of healthy volunteers (A) or patients with ALD (B) are shown. Molecular weights and
a schematic representation of each isoform are indicated on each spectra where required. Representative spectra of the tandem MS characterization of a
peptide containing lysine residues (Lys-28, -29, and -30) within NLS1 (C) and lysine residues (Lys-180, -182, -183, -184, and -185) within NLS2 (D) after Glu-C
digestion of the 25,467- and 25,549-Da human HMGB1 isoforms following extraction from the serum of ALD patients are shown. HMGB1 was enzymatically
cleaved with endopeptidase Glu-C to confirm the presence or absence of acetyl modifications on specific lysine residues (shown as K(Ac)) as described under
“Experimental Procedures.” The one-letter amino acid code is given for each peptide sequence, and b and y ions are labeled with molecular weights and amino
acid code where appropriate. Data are representative of either 10 healthy volunteers or 10 ALD patients.
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A key observation was the significant cytoplasmic HMGB1
staining in human and mouse samples from ALD. Although
HMGB1 contains 43 lysines, only eight lysines in two key clus-
ters appear to play a major role in preventing HMGB1 nuclear
reentry due to PTMs: lysines 28 –30 and lysines 43– 44 repre-
senting a classic bipartite and functional NLS1 (1, 52) and
lysines 180 and 182–185 within NLS2 (1, 52). Cells exclude
HMGB1 from the nucleus by acetylating lysines, thereby neu-
tralizing their basic charge and rendering them unable to func-
tion as NLSs. Thus, whether the identified ethanol-induced
acetylation tilts the balance by inhibiting nuclear import, pro-
moting HMGB1 accumulation in the cytoplasm perhaps for
subsequent secretion, remains an open question (3).
Passive and active HMGB1 export to the extracellular milieu
differs in that HMGB1 is highly acetylated for secretion,
whereas passively released HMGB1 is not. Therefore, the iden-
tification of acetylated HMGB1 in the serum from alcoholic
patients and in a murine model of ALD indicates that an active
TABLE 1
Summary of the PTMs identified in HMGB1 in serum and liver from control and ethanol-fed mice and serum of healthy volunteers and alcoholic
patients
PTMs were characterized by ESI-LC-MS as described under “Experimental Procedures.” With respect to redox characterization, “Disulfide” represents HMGB1 with a
disulfide bond between cysteines 23 and 45 and a reduced cysteine 106, and “All thiol” represents HMGB1 with all cysteine residues reduced. “Acetylated” and “Non
Acetylated” refer to the identification of lysines within NLS1 (lysines 28 –30) and NLS2 (lysines 180 and 182–185) with and without acetyl modifications, respectively. “Phos
Ser 35” and “Non Phos Ser 35” refer to the serine 35 with and without a phosphorylation modification, respectively. Relative quantification of HMGB1 isoforms is based on
the area under the ESI-LC-MS curve (AUC) for a particular diagnostic peptide containing the key amino acid of interest for the PTM investigated. Extracted ion counts were
normalized for total ion count. Peptides containing amino acids 13–24, 45– 48, and 97–112 were used to quantify redox-dependent modifications, and peptides containing
amino acids 26 –39 and 180 –188 were used for phospho and acetyl modifications, respectively. When no modification could be found, the lowest detectable area under the
curve was recorded.
TABLE 2
Summary of PTMs identified in HMGB1 in hepatocytes and Kupffer cells isolated from control and ethanol-fed mice
PTMs were characterized by ESI-LC-MS as described under “Experimental Procedures.” With respect to redox characterization, “Disulfide” represents HMGB1 with a
disulfide bond between cysteines 23 and 45 and a reduced cysteine 106, and “All thiol” represents HMGB1 with all cysteine residues reduced. “Acetylated” and “Non
Acetylated” refer to the identification of lysines within NLS1 (lysines 28 –30) and NLS2 (lysines 180 and 182–185) with and without acetyl modifications, respectively. “Phos
Ser 35” and “Non Phos Ser 35” refer to serine 35 with and without a phosphorylation modification, respectively. HMGB1 isoforms were quantified based on the area under
the ESI-LC-MS curve (AUC) for a particular diagnostic peptide containing the key amino acid of interest for the PTM investigated. Extracted ion counts were normalized
for total ion count. Peptides containing amino acids 13–24, 45– 48, and 97–112 were used to quantify redox-dependent modifications, and peptides containing amino acids
26 –39 and 180 –188 were used for phospho and acetyl modifications, respectively. The -fold increase in the area under the curve induced by ethanol treatment compared
with control is also included for comparison.
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release of HMGB1 from hepatocytes and to a lesser extent from
Kupffer cells, as shown in the culture medium from both cell
types, may occur to drive ongoing inflammatory processes
while perhaps serving as a translational biomarker of ALD;
however, additional work is necessary to prove this. This PTM
could reveal novel pathways for therapeutic intervention by tar-
geting the acetylation process itself to block harmful secretion
of HMGB1 during ALD.
In this study, we also detected significant oxidation of
HMGB1. Recent evidence from preclinical and in vitro studies
has revealed that the proinflammatory activity of HMGB1 is
highly modulated by redox-dependent PTMs of three con-
served cysteine residues at positions 23, 45, and 106. Cysteines
23 and 45 undergo conformational changes in response to oxi-
dative stress and can form an intramolecular disulfide bond,
whereas cysteine 106 is unpaired and has been shown to be
essential for HMGB1 translocation from the nucleus to the
cytoplasm (53) and for binding toll-like receptor-4 when pres-
ent in its reduced state.
Similar findings were observed in ALD. Alcohol-induced
liver injury causes significant oxidant stress due to alcohol
metabolism via cytochrome P450 2E1; therefore, some HMGB1
oxidation was anticipated to occur in this setting. Besides, a
more oxidizing environment due to the increase in reactive
oxygen species and to GSH depletion under alcohol intake
would favor HMGB1 oxidation.
Recruitment of neutrophils and macrophages and their acti-
vation to release proinflammatory cytokines contribute to ster-
ile inflammation in ALD. It is possible that HMGB1 may play a
role in this process by switching among mutually exclusive
redox states. With all cysteines reduced, HMGB1 could act as a
chemoattractant, whereas a disulfide bond between cysteines
23 and 45 could enable toll-like receptor-4 interactions and
eventually promote cytokine production. Terminal oxidation
to sulfonates by reactive oxygen species could then abrogate
both activities (51). In ALD, HMGB1 could likely be completely
reduced at first and disulfide-bonded later due to the alcohol-
induced oxidative burst. Thus, HMGB1 could orchestrate both
events (leukocyte recruitment and their activation to secrete
inflammatory cytokines by adopting mutually exclusive forms)
in sterile inflammation in ALD. However, additional studies are
necessary to validate this speculation. Interestingly, we noted
that in vitro only hepatocytes, but not Kupffer cells, released
disulfide-bonded HMGB1 in response to ethanol, suggesting
that they could be the initial source of mediators that could
drive cytokine production in ALD.
Finally, within this current investigation, we also reported
the novel identification of phosphorylated serine 35 in HMGB1
in both human and murine serum and liver samples from ALD.
Phosphorylation in the two NLSs is key for the nuclear to cyto-
plasmic transport and secretion of HMGB1 (54). Of 14 poten-
tial phosphorylation sites, six are located within NLSs, but only
serine 35 appeared phosphorylated in ALD. Ethanol-induced
HMGB1 phosphorylation could increase the thermal stability
of HMGB1, decrease its affinity for linear DNA (55), and favor
binding to the nuclear exportin CRM1 for migration to the
cytoplasm (1) in addition to disrupting the interaction of
HMGB1 with nuclear importin (34). Phosphorylation of serines
35, 39, and 42 in NLS1 in HMGB1 is critical for HMGB1 trans-
location into the cytoplasm (56). HMGB1 serine residues can be
phosphorylated by TNF and is then relocated toward secre-
tion and does not re-enter the nucleus (54). Because of the
major role of TNF in ALD, it is possible that it may be a driver
of HMGB1 phosphorylation and eventually secretion. Future
studies will clarify this hypothesis. Lastly, phosphorylation of
serines 35, 53, and 181 by PKC- has been described to enhance
HMGB1 secretion in HCT116 colon cancer cells (57).
In summary, the data presented here implicate a potential
key role of HMGB1 in the pathogenesis of ALD. Furthermore,
the novel identification of mostly hepatocyte-derived HMGB1
isoforms may provide enhanced mechanistic insights to iden-
tify novel targets for therapeutic intervention or biomarkers to
enable patient stratification and eventually treatment.
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